General Information of the Molecule (ID: Mol01789)
Name
piR-l-138 ,Homo sapiens
Molecule Type
Piwi-interacting RNA
        Click to Show/Hide the Complete Species Lineage
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Type(s) of Resistant Mechanism of This Molecule
  EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Click to Show/Hide the Full List of Drugs
Cisplatin
Click to Show/Hide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms
       Epigenetic Alteration of DNA, RNA or Protein (EADR) Click to Show/Hide
Disease Class: Lung squamous cell carcinoma [1]
Sensitive Disease Lung squamous cell carcinoma [ICD-11: 2C25.3]
Sensitive Drug Cisplatin
Molecule Alteration Expression
Up-regulation
Experimental Note Revealed Based on the Cell Line Data
In Vitro Model Sk-MES-1 cells Lung Homo sapiens (Human) CVCL_0630
H157 cells Lung Homo sapiens (Human) CVCL_2458
NCl-H226 cells Lung Homo sapiens (Human) CVCL_1544
NCI-H522 cells Lung Homo sapiens (Human) CVCL_1567
NCl-H1437 cells Lung Homo sapiens (Human) CVCL_1472
NCl-H1792 cells Lung Homo sapiens (Human) CVCL_1495
NCl-H1944 cells Lung Homo sapiens (Human) CVCL_1508
NCl-H596 cells Lung Homo sapiens (Human) CVCL_1571
In Vivo Model Nude mouse xenograft model Mus musculus
Experiment for
Molecule Alteration
RT-PCR
Experiment for
Drug Resistance
MTT assay
Mechanism Description piR-L-138 directly interacted with p60-MDM2 and inhibited CDDP-activated apoptosis in p53-mutated LSCC.
References
Ref 1 A piRNA-like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma. Mol Ther Nucleic Acids. 2017 Mar 17;6:269-278. doi: 10.1016/j.omtn.2017.01.003. Epub 2017 Jan 24.
insuranceusa.com
visits since 2022

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.